Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial
- PMID: 21308882
- PMCID: PMC3079416
- DOI: 10.1002/da.20758
Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial
Abstract
Background: To date, few randomized controlled trials (RCTs) of major depression have examined suicidal ideation as an outcome measure. Our aim is to determine the incidence of treatment-emergent suicidal ideation (ESI) and behaviors during the acute phase of treatment with an SSRI antidepressant or interpersonal psychotherapy (IPT) in patients with unipolar major depression.
Methods: In a two-site RCT, 291 adult outpatients with nonpsychotic major depression and a Hamilton Depression Rating Scale (HDRS) score ≥15 were randomly allocated to IPT or SSRI. Participants who did not remit with monotherapy received augmentation with the other treatment. ESI was defined as a post-baseline HDRS suicidality item score ≥2 or a post-baseline Quick Inventory of Depressive Symptomatology (QIDS) score ≥2 in patients with a baseline score ≤1.
Results: Of the 231 participants who had no suicidal ideation at baseline, 32 (13.8%) subsequently exhibited ESI on at least one post-baseline visit. Time to suicidal ideation was significantly longer in patients allocated to SSRI compared to those allocated to IPT (HR = 2.21, 95% CI 1.04-4.66, P = .038), even after controlling for treatment augmentation, benzodiazepine use, and comorbidity with anxiety disorders. Worsening of suicidal ideation occurred in 7/60 patients who had suicidal ideation at baseline. In the large majority of cases, suicidal ideation was successfully managed with the study protocol.
Conclusions: In the context of careful monitoring and frequent contact, selective serotonin reuptake inhibitor (SSRI) was associated with a lower risk of ESI than IPT and both SSRI and IPT appeared to be safe treatments for patients with past suicide attempts, none of whom exhibited ESI during the study.
© 2011 Wiley-Liss, Inc.
Figures
Similar articles
-
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.Arch Gen Psychiatry. 2007 Jun;64(6):689-97. doi: 10.1001/archpsyc.64.6.689. Arch Gen Psychiatry. 2007. PMID: 17548750 Clinical Trial.
-
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.J Clin Psychiatry. 2012 Jul;73(7):967-76. doi: 10.4088/JCP.11m07043. Epub 2012 May 29. J Clin Psychiatry. 2012. PMID: 22687487 Clinical Trial.
-
SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.J Clin Psychiatry. 2013 Sep;74(9):872-9. doi: 10.4088/JCP.12m08000. J Clin Psychiatry. 2013. PMID: 24107760 Free PMC article. Clinical Trial.
-
Pharmacotherapy in depressed children and adolescents.World J Biol Psychiatry. 2011 Sep;12 Suppl 1:11-5. doi: 10.3109/15622975.2011.600295. World J Biol Psychiatry. 2011. PMID: 21905988 Review.
-
[Efficacy and tolerability of escitalopram in anxiety disorders: a review].Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Encephale. 2008. PMID: 18922243 Review. French.
Cited by
-
Clinical Efficacy of Ketamine for Treatment-resistant Depression.Cureus. 2019 Jul 22;11(7):e5189. doi: 10.7759/cureus.5189. Cureus. 2019. PMID: 31565597 Free PMC article. Review.
-
Interpersonal Psychotherapy for Suicidal Risk: A Narrative Review of Randomized Controlled Trials.Indian J Psychol Med. 2025 Jun 17:02537176251347066. doi: 10.1177/02537176251347066. Online ahead of print. Indian J Psychol Med. 2025. PMID: 40547350 Free PMC article. Review.
-
The Importance of Psychotherapy for Treatment-Resistant Depression.Adv Exp Med Biol. 2024;1456:257-271. doi: 10.1007/978-981-97-4402-2_13. Adv Exp Med Biol. 2024. PMID: 39261433 Review.
-
Cognitive therapy and interpersonal psychotherapy reduce suicidal ideation independent from their effect on depression.Depress Anxiety. 2021 Sep;38(9):940-949. doi: 10.1002/da.23151. Epub 2021 Mar 23. Depress Anxiety. 2021. PMID: 33755280 Free PMC article. Clinical Trial.
-
Genome-wide association study of antidepressant treatment-emergent suicidal ideation.Neuropsychopharmacology. 2012 Feb;37(3):797-807. doi: 10.1038/npp.2011.257. Epub 2011 Oct 26. Neuropsychopharmacology. 2012. PMID: 22030708 Free PMC article.
References
-
- Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures and attempts in the United States, 1990-1992 to 2001-2003. JAMA. 2005;293:2487–2495. - PubMed
-
- Sokero P, Melartin T, Rytsala H, Leskela U, Lestela-Mielonen P, Isometsa E. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clinical Psychiatry. 2003;64:1094–1100. - PubMed
-
- Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332–339. - PubMed
-
- Szanto K, Mulsant BH, Houck PR, et al. Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age. J Affect Disord. 2007;98(1-2):153–161. - PubMed
-
- Perlis RH, Beasley CM, Jr, Wines JD, Jr, et al. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychother Psychosom. 2007;76(1):40–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous